Introduction
Bay Pharma is committed to operating in an ethical, transparent, and socially responsible manner. We recognise the serious global issue of modern slavery and human trafficking and are dedicated to ensuring that our operations and supply chains are free from these practices.

Our Business
Bay Pharma is an Australian-based supplier of therapeutic vaping products, operating within the pharmaceutical industry. We supply products that meet strict quality, safety, and regulatory standards, partnering with reputable manufacturers and distributors both domestically and internationally.

Our Commitment
We believe that all people should be treated with dignity and respect. We do not tolerate any form of modern slavery, including forced labour, child labour, servitude, debt bondage, human trafficking, or deceptive recruiting for labour or services, within our operations or supply chain.

Our Supply Chain
Our supply chain includes:

• Manufacturers and component suppliers
• Logistics and distribution partners
• Professional service providers

We work closely with our partners to ensure they share our values and meet our compliance expectations. Where possible, we engage suppliers who can demonstrate strong labour and ethical practices, and we actively review supplier compliance with relevant laws and standards.

Policies and Due Diligence
Bay Pharma has internal policies and procedures in place to support our commitment to ethical business conduct, including:

• Supplier agreements requiring compliance with Australian workplace laws and international labour standards.
• Ongoing risk assessment of our supply chain to identify potential areas of concern.
• Regular communication with suppliers regarding ethical sourcing and modern slavery awareness.

Reporting Concerns
We encourage staff, suppliers, and partners to report any suspected instances of modern slavery or unethical labour practices. All reports are taken seriously and investigated promptly.

Continuous Improvement
We are committed to continuously improving our practices to identify, prevent, and address modern slavery risks. As our business grows, we will regularly review our policies, procedures, and supplier engagement strategies to strengthen protections against modern slavery.

Approval
This statement has been approved by the Directors of Bay Pharma and will be reviewed annually to ensure it remains relevant and effective.